Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Complete Health Indicator Report of Immunizations: pneumonia, adults

Definition

Percentage of adults 65+ who reported receiving a pneumococcal vaccination at any point in their lifetime.

Numerator

Number of survey respondents age 65+ who reported receiving a pneomococcal vaccine anytime during their life.

Denominator

Number of survey respondents age 65+.

Why Is This Important?

Pneumococcal disease is caused by bacteria that can spread from person to person through close contact. It can cause ear infections, and it can also lead to more serious infections of the lungs (pneumonia), blood (bacteremia), and covering of the brain and spinal cord (meningitis). Anyone can get pneumococcal disease, but children under two years of age and adults aged 65 years and older, people with certain medical conditions, and cigarette smokers are at the highest risk. [[br]] Before there was a vaccine, the United States saw: *More than 700 cases of meningitis *About 13,000 blood infections *About 5 million ear infections *About 200 deaths Pneumococcal disease is common in young children, but older adults are at greatest risk of serious illness and death. Pneumococcal vaccines help protect against pneumococcal infections, including invasive disease^1^. [[br]] ====Pneumococcal Vaccines==== There are three pneumococcal vaccines that are recommended for use in the United States: *Pneumococcal conjugate vaccine (PCV15/VAXNEUVANCE, PCV20/Prevnar 20) *Pneumococcal polysaccharide vaccine (PPSV23/Pneumovax23)[[br]] [[br]] The pneumococcal conjugate vaccines (PCV15/VAXNEUVANCE, PCV20/Prevnar 20) are recommended for: *Children at 2, 4, 6, and 12 through 15 months old and up to 5 years for those who missed doses *Adults 65 years or older *Children 5 years or older with certain medical conditions *Adults aged 18 to 64 years with certain medical conditions [[br]] The pneumococcal polysaccharide vaccine (PPSV23) is recommended for: *Children 2 through 18 years old with certain medical conditions *Adults who receive PCV15 *Adults who have received an earlier vaccine called PCV13^2^ [[br]] A 2006 study published in the medical journal Clinical Infectious Diseases found that hospital patients who received the pneumococcal vaccine were 40 to 70 percent less likely to die than unvaccinated patients. In the study, vaccinated patients had a lower risk of respiratory failure, kidney failure, heart attack, and other complications. Vaccinated patients in the study also spent an average of two fewer days in the hospital^3^.[[br]] [[br]] ---- 1. Centers for Disease Control and Prevention (CDC). ''Pneumococcal Vaccination: Why Getting Vaccinated is important''. Retrieved from: [https://www.cdc.gov/pneumococcal/vaccines/index.html#cdc_vaccine_basics_get_vaccinated-why-getting-vaccinated-is-important] [[br]] 2. Centers for Disease Control and Prevention (CDC). ''Pneumococcal Vaccination: What Everyone Should Know'' Retrieved from: [https://www.cdc.gov/vaccines/vpd/pneumo/public/index.html][[br]] 3. Vila-Crcoles, et al. Protective Effects of the 23-Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN-65 Study. ''Clinical Infectious Diseases''. Retrieved from: [http://cid.oxfordjournals.org/content/43/7/860.full]

Other Objectives

[[br]] ===Healthy People 2030 related objectives:=== IID-D03: Increase the proportion of adults age 19 years or older who get recommended vaccines[[br]]

How Are We Doing?

Lifetime pneumococcal vaccination rates for Utah adults 65+ have significantly improved since 1997 when data were first collected on the BRFSS. The 2001 rate was 67.3% and by 2020 the rate had increased to 74.5%. However, due to a change in the BRFSS methodology in 2011, it is not possible to know if this is a significant change. Rates have remained above 70% since 2015.

How Do We Compare With the U.S.?

In 2023, the pneumococcal vaccination rate for adults age 65+ in the United States was 70.2%, while the Utah rate was 72.0%.

Available Services

The Utah Immunization Program continues to administer the Vaccines for Adults (Utah-VFA) which provides the following vaccines for uninsured adults who are at risk for contracting hepatitis B: *Hepatitis A & B vaccine *Human Papillomavirus vaccine *Pneumococcal polysaccharide vaccine *Tetanus, diphtheria & pertussis vaccine [[br]] [[br]] Adults at high risk for contracting Hepatitis B may be able to access PPSV vaccine through this program.


Related Indicators

Related Relevant Population Characteristics Indicators:


Related Health Care System Factors Indicators:


Related Risk Factors Indicators:





Graphical Data Views

Percentage of adults 65+ who reported having ever received pneumococcal vaccination, Utah and U.S., 2002-2023

::chart - missing::
confidence limits

BRFSS Utah vs. U.S.YearPercentage of adults age 65+Lower LimitUpper Limit
Record Count: 44
UT Old Methodology200265.0%60.3%69.7%
UT Old Methodology200366.2%61.4%71.0%
UT Old Methodology200465.8%62.1%69.5%
UT Old Methodology200566.4%62.9%69.9%
UT Old Methodology200665.9%62.4%69.4%
UT Old Methodology200768.8%65.4%72.0%
UT Old Methodology200869.2%65.9%72.2%
UT Old Methodology200969.0%66.7%71.2%
UT Old Methodology201068.5%66.3%70.6%
US Old Methodology200263.0%59.2%65.9%
US Old Methodology200364.7%61.8%68.6%
US Old Methodology200464.7%62.1%67.9%
US Old Methodology200565.9%62.5%69.2%
US Old Methodology200666.9%64.1%69.5%
US Old Methodology200765.8%65.2%66.4%
US Old Methodology200865.7%65.2%66.2%
US Old Methodology200966.9%66.4%67.4%
US Old Methodology201068.2%67.8%68.6%
UT New Methodology201170.0%67.8%72.2%
UT New Methodology201270.1%68.1%72.1%
UT New Methodology201369.4%67.2%71.6%
UT New Methodology201469.3%67.4%71.3%
UT New Methodology201572.1%69.6%74.4%
UT New Methodology201674.3%72.1%76.4%
UT New Methodology201773.9%71.5%76.1%
UT New Methodology201873.7%71.5%75.8%
UT New Methodology201976.1%74.2%77.9%
UT New Methodology202074.5%72.4%76.4%
UT New Methodology202173.4%71.2%75.4%
UT New Methodology202273.9%71.5%76.1%
UT New Methodology202372.0%69.8%74.2%
US New Methodology201169.6%69.1%70.1%
US New Methodology201268.3%67.7%68.8%
US New Methodology201368.4%67.9%68.9%
US New Methodology201469.4%68.8%69.9%
US New Methodology201571.9%71.4%72.4%
US New Methodology201672.4%71.9%72.9%
US New Methodology201774.7%74.2%75.3%
US New Methodology201871.8%71.2%72.4%
US New Methodology201971.7%71.2%72.2%
US New Methodology202070.3%69.6%71.0%
US New Methodology202170.1%69.5%70.7%
US New Methodology202270.0%69.4%70.5%
US New Methodology202370.2%69.7%70.8%

Data Notes

Beginning in 2011, BRFSS data include both landline and cell phone respondent data along with a new weighting methodology called iterative proportional fitting, or raking. This methodology utilizes additional demographic information (such as education, race, and marital status) in the weighting procedure. Both of these methodology changes were implemented to account for an increased number of U.S. households without landline phones and an under-representation of certain demographic groups that were not well-represented in the sample. More details about these changes can be found at: [https://ibis.utah.gov/ibisph-view/pdf/opha/resource/brfss/RakingImpact2011.pdf]

Data Sources

  • Utah Department of Health and Human Services Behavioral Risk Factor Surveillance System (BRFSS) [https://ibis.utah.gov/ibisph-view/query/selection/brfss/BRFSSSelection.html]
  • Behavioral Risk Factor Surveillance System Survey Data, US Department of Health and Human Services Centers for Disease Control and Prevention (CDC).


Ever received pneumococcal vaccination by local health district, Utah adults aged 65+, 2023

::chart - missing::
confidence limits

Local health districtPercentage of adults 65+Lower LimitUpper LimitNote
Record Count: 15
Bear River72.2%59.4%82.1%
Central61.4%52.5%69.6%
Davis County77.2%69.4%83.5%
Salt Lake County77.9%73.9%81.4%
San Juan55.3%40.4%69.4%
Southeast51.5%40.4%62.4%
Southwest64.8%58.0%71.0%
Summit74.2%61.5%83.8%
Tooele67.5%56.6%76.8%
TriCounty58.8%47.8%69.0%
Utah County69.8%63.7%75.5%
Wasatch77.2%58.8%88.9%*
Weber-Morgan74.9%68.2%80.6%
State of Utah72.0%69.8%74.2%
U.S.70.2%69.7%70.8%

Data Notes

*Use caution in interpreting; the estimate has a relative standard error greater than 30% and does not meet DHHS standards for reliability. Beginning in 2011, BRFSS data include both landline and cell phone respondent data along with a new weighting methodology called iterative proportional fitting, or raking. This methodology utilizes additional demographic information (such as education, race, and marital status) in the weighting procedure. Both of these methodology changes were implemented to account for an increased number of U.S. households without landline phones and an under-representation of certain demographic groups that were not well-represented in the sample. This graph is based on the new methodology. More details about these changes can be found at: [https://ibis.utah.gov/ibisph-view/pdf/opha/resource/brfss/RakingImpact2011.pdf]

Data Sources

  • Utah Department of Health and Human Services Behavioral Risk Factor Surveillance System (BRFSS) [https://ibis.utah.gov/ibisph-view/query/selection/brfss/BRFSSSelection.html]
  • Behavioral Risk Factor Surveillance System Survey Data, US Department of Health and Human Services Centers for Disease Control and Prevention (CDC).

More Resources and Links

Additional indicator data by state and county may be found on these websites:

Medical literature can be queried at PubMed library.

Page Content Updated On 10/02/2024, Published on 10/07/2024
The information provided above is from the Utah Department of Health and Human Services IBIS-PH website (https://ibis.utah.gov/ibisph-view/). The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Mon, 23 December 2024 0:46:54 from Utah Department of Health and Human Services, Indicator-Based Information System for Public Health website: https://ibis.utah.gov/ibisph-view/ ".

Content updated: Mon, 7 Oct 2024 16:01:43 MDT